| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of CTNNB1 protein | CTD | PMID:12387456 |
| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:733705 | 6480464 | epigallocatechin gallate results in decreased expression of CTNNB1 mRNA; more ... | CTD | PMID:16968065 |
| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:1550466 | 6480464 | epigallocatechin gallate results in decreased expression of CTNNB1 protein | CTD | PMID:12351151 |
| (-)-epigallocatechin 3-gallate | decreases localization | ISO | RGD:733705 | 6480464 | epigallocatechin gallate results in decreased localization of CTNNB1 protein | CTD | PMID:16968065 |
| (-)-epigallocatechin 3-gallate | decreases phosphorylation | ISO | RGD:733705 | 6480464 | epigallocatechin gallate results in decreased phosphorylation of CTNNB1 protein | CTD | PMID:16968065 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | increases expression | ISO | RGD:733705 | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA | CTD | PMID:16580782 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | multiple interactions | ISO | RGD:733705 | 6480464 | CDH2 protein affects the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA] | CTD | PMID:16580782 |
| 1,2-dimethylhydrazine | increases mutagenesis | EXP | | 6480464 | 1,2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene | CTD | PMID:12628520 |
| 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | chlorophyllin affects the reaction [1,2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene] | CTD | PMID:12628520 |
| 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [chlorophyllin affects the reaction [1,2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene]] inhibits the reaction [GSK3B protein results in increased phosphorylation of and results in increased ubiquitination of CTNNB1 protein] | CTD | PMID:12628520 PMID:12628520 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1550466 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:733705 | 6480464 | Estradiol results in increased expression of and affects the localization of CTNNB1 protein | CTD | PMID:16053526 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol promotes the reaction [CTNNB1 protein binds to LEF1 protein] | CTD | PMID:17170212 |
| 17beta-estradiol | affects localization | EXP | | 6480464 | Estradiol affects the localization of CTNNB1 protein | CTD | PMID:17170212 |
| 17beta-estradiol | increases expression | ISO | RGD:1550466 | 6480464 | Estradiol results in increased expression of CTNNB1 mRNA | CTD | PMID:14648872 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1550466 | 6480464 | [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein | CTD | PMID:11786374 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:733705 | 6480464 | Metribolone promotes the reaction [NDRG1 protein binds to CTNNB1 protein] | CTD | PMID:17220478 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases degradation | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased degradation of CTNNB1 protein | CTD | PMID:19464575 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased phosphorylation of and results in decreased activity of CTNNB1 protein; more ... | CTD | PMID:19464575 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550466 | 6480464 | CTNNB1 protein affects the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA] | CTD | PMID:21498875 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733705 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein | CTD | PMID:22902829 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1550466 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CTNNB1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733705 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein | CTD | PMID:22134133 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein] | CTD | PMID:22134133 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of CTNNB1 protein modified form | CTD | PMID:21602191 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550466 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CTNNB1 mRNA | CTD | PMID:17586704 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550466 | 6480464 | WNT3A protein promotes the reaction [[Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of CTNNB1 protein]; more ... | CTD | PMID:21602191 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550466 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA | CTD | PMID:17942748 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | ISO | RGD:1550466 | 6480464 | [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein; more ... | CTD | PMID:16272459 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of CTNNB1 mRNA | CTD | PMID:21346803 |
| 2-methoxy-17beta-estradiol | decreases expression | ISO | RGD:733705 | 6480464 | 2-methoxyestradiol results in decreased expression of CTNNB1 mRNA; more ... | CTD | PMID:18485479 |
| 2-methoxy-17beta-estradiol | multiple interactions | ISO | RGD:733705 | 6480464 | 2-methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to bortezomib] | CTD | PMID:18485479 |
| 2-nitrotoluene | increases mutagenesis | ISO | RGD:1550466 | 6480464 | 2-nitrotoluene results in increased mutagenesis of CTNNB1 gene | CTD | PMID:13678655 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | decreases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in decreased expression of CTNNB1 protein | CTD | PMID:12065681 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1550466 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CTNNB1 mRNA | CTD | PMID:20188158 |
| 3-aminobenzamide | decreases expression | ISO | RGD:733705 | 6480464 | 3-aminobenzamide results in decreased expression of CTNNB1 mRNA | CTD | PMID:15670817 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:1550466 | 6480464 | CTNNB1 protein affects the reaction [[Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA] | CTD | PMID:21498875 |
| 3-methylcholanthrene | affects response to substance | ISO | RGD:1550466 | 6480464 | CTNNB1 protein affects the susceptibility to Methylcholanthrene | CTD | PMID:21498875 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1550466 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CTNNB1 mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:733705 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 mRNA | CTD | PMID:12419474 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | increases expression | ISO | RGD:1550466 | 6480464 | AICA ribonucleotide results in increased expression of CTNNB1 mRNA; more ... | CTD | PMID:21454484 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:1550466 | 6480464 | AICA ribonucleotide inhibits the reaction [[HDAC5 protein binds to MEF2 protein] which binds to CTNNB1 promoter]; more ... | CTD | PMID:21454484 |
| 5-aza-2'-deoxycytidine | decreases response to substance | ISO | RGD:733705 | 6480464 | CTNNB1 protein results in decreased susceptibility to decitabine | CTD | PMID:19234609 |
| 5-aza-2'-deoxycytidine | decreases localization | ISO | RGD:733705 | 6480464 | decitabine results in decreased localization of CTNNB1 protein | CTD | PMID:21515334 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1550466 | 6480464 | decitabine results in decreased expression of CTNNB1 mRNA | CTD | PMID:19222872 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:733705 | 6480464 | decitabine results in increased expression of CTNNB1 protein | CTD | PMID:19234609 |
| 5-aza-2'-deoxycytidine | affects localization | ISO | RGD:733705 | 6480464 | decitabine affects the localization of CTNNB1 protein | CTD | PMID:19387464 |
| acetylsalicylic acid | decreases localization | ISO | RGD:733705 | 6480464 | Aspirin results in decreased localization of CTNNB1 protein | CTD | PMID:16878161 PMID:17357503 |
| acetylsalicylic acid | decreases localization | ISO | RGD:733705 | 6480464 | Aspirin results in decreased localization of CTNNB1 protein | CTD | PMID:17357503 PMID:16878161 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride inhibits the reaction [Aspirin results in increased phosphorylation of CTNNB1 protein] | CTD | PMID:12813129 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:733705 | 6480464 | CTNNB1 affects the reaction [Aspirin results in decreased expression of CCND1 protein]; more ... | CTD | PMID:16878161 |
| acetylsalicylic acid | increases ubiquitination | ISO | RGD:733705 | 6480464 | Aspirin results in increased ubiquitination of CTNNB1 protein | CTD | PMID:16878161 |
| acetylsalicylic acid | decreases localization | ISO | RGD:733705 | 6480464 | Aspirin results in decreased localization of CTNNB1 protein | CTD | PMID:16878161 |
| acetylsalicylic acid | increases phosphorylation | ISO | RGD:733705 | 6480464 | Aspirin results in increased phosphorylation of CTNNB1 protein | CTD | PMID:12813129 PMID:16878161 |
| acetylsalicylic acid | increases phosphorylation | ISO | RGD:733705 | 6480464 | Aspirin results in increased phosphorylation of CTNNB1 protein | CTD | PMID:16878161 PMID:12813129 |
| acrolein | increases expression | ISO | RGD:733705 | 6480464 | Acrolein results in increased expression of CTNNB1 protein | CTD | PMID:20525806 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1550466 | 6480464 | [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein; more ... | CTD | PMID:17170073 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1550466 | 6480464 | Tretinoin results in decreased expression of CTNNB1 protein | CTD | PMID:17064353 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1550466 | 6480464 | Tretinoin results in increased expression of CTNNB1 mRNA | CTD | PMID:16236135 |
| all-trans-retinoic acid | increases expression | ISO | RGD:733705 | 6480464 | Tretinoin results in increased expression of CTNNB1 protein | CTD | PMID:17219422 |
| all-trans-retinol | multiple interactions | ISO | RGD:733705 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein]; more ... | CTD | PMID:17219422 |
| all-trans-retinol | decreases expression | ISO | RGD:733705 | 6480464 | Vitamin A results in decreased expression of CTNNB1 protein | CTD | PMID:17219422 |
| ammonia | affects metabolic processing | ISO | RGD:1550466 | 6480464 | CTNNB1 protein affects the metabolism of Ammonia | CTD | PMID:16557553 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CTNNB1 mRNA | CTD | PMID:16483693 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of CTNNB1 protein | CTD | PMID:16483693 |
| amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of CTNNB1 protein | CTD | PMID:16144542 |
| arsenic atom | multiple interactions | ISO | RGD:733705 | 6480464 | Arsenic results in increased expression of and results in increased activity of CTNNB1 protein; more ... | CTD | PMID:22552367 |
| arsenic atom | increases expression | ISO | RGD:1550466 | 6480464 | Arsenic results in increased expression of CTNNB1 protein | CTD | PMID:22552367 |
| arsenic trichloride | increases expression | ISO | RGD:733705 | 6480464 | arsenic trichloride results in increased expression of CTNNB1 protein | CTD | PMID:21854796 |
| arsenic trichloride | multiple interactions | ISO | RGD:733705 | 6480464 | CAT protein inhibits the reaction [arsenic trichloride results in increased expression of CTNNB1 protein]; more ... | CTD | PMID:21854796 |
| arsenic trichloride | increases activity | ISO | RGD:733705 | 6480464 | arsenic trichloride results in increased activity of CTNNB1 protein | CTD | PMID:21854796 |
| arsenite(3-) | affects localization | ISO | RGD:733705 | 6480464 | arsenite affects the localization of CTNNB1 protein | CTD | PMID:17400267 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CTNNB1 protein | CTD | PMID:21344382 |
| arsenite(3-) | multiple interactions | ISO | RGD:733705 | 6480464 | tyrphostin AG 1478 inhibits the reaction [arsenite affects the localization of CTNNB1 protein] | CTD | PMID:17400267 |
| arsenite(3-) | decreases phosphorylation | ISO | RGD:733705 | 6480464 | arsenite results in decreased phosphorylation of CTNNB1 protein | CTD | PMID:17400267 |
| atropine | multiple interactions | ISO | RGD:733705 | 6480464 | Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form]; more ... | CTD | PMID:17390078 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1550466 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] affects the expression of CTNNB1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:733705 | 6480464 | Benzo(a)pyrene results in increased expression of CTNNB1 mRNA | CTD | PMID:21714911 |
| benzo[a]pyrene | increases expression | ISO | RGD:1550466 | 6480464 | Benzo(a)pyrene results in increased expression of CTNNB1 mRNA | CTD | PMID:22228805 |
| bis(2-ethylhexyl) phthalate | affects localization | ISO | RGD:1550466 | 6480464 | Diethylhexyl Phthalate affects the localization of CTNNB1 protein | CTD | PMID:20307648 |
| bromocriptine | multiple interactions | ISO | RGD:1550466 | 6480464 | [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein | CTD | PMID:11786374 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of CTNNB1 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | affects localization | EXP | | 6480464 | Cadmium Chloride affects the localization of CTNNB1 protein | CTD | PMID:20459685 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Cadmium Chloride results in increased expression of and affects the localization of CTNNB1 protein | CTD | PMID:19615436 |
| cadmium dichloride | multiple interactions | ISO | RGD:1550466 | 6480464 | Cadmium Chloride results in increased phosphorylation of and affects the localization of CTNNB1 protein | CTD | PMID:19818801 |
| cadmium dichloride | decreases activity | ISO | RGD:1550466 | 6480464 | Cadmium Chloride results in decreased activity of CTNNB1 protein | CTD | PMID:19818801 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | N(6),N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of CTNNB1 protein] | CTD | PMID:15618353 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CTNNB1 protein | CTD | PMID:15618353 |
| cadmium dichloride | affects expression | ISO | RGD:1550466 | 6480464 | Cadmium Chloride affects the expression of CTNNB1 mRNA | CTD | PMID:18974090 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Cadmium Chloride inhibits the reaction [CTNNB1 protein binds to CDH1 protein binds to CTNNA1 protein]; more ... | CTD | PMID:20459685 |
| caffeine | increases mutagenesis | EXP | | 6480464 | Caffeine results in increased mutagenesis of CTNNB1 gene | CTD | PMID:18283038 |
| calciol | multiple interactions | ISO | RGD:1550466 | 6480464 | [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein; more ... | CTD | PMID:17170073 |
| calciol | increases expression | ISO | RGD:1550466 | 6480464 | Cholecalciferol results in increased expression of CTNNB1 mRNA | CTD | PMID:17170073 |
| calcitriol | multiple interactions | ISO | RGD:733705 | 6480464 | Calcitriol promotes the reaction [CTNNB1 protein binds to VDR protein] | CTD | PMID:16051482 |
| calcitriol | decreases activity | ISO | RGD:733705 | 6480464 | Calcitriol results in decreased activity of CTNNB1 protein | CTD | PMID:16051482 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of CTNNB1 protein | CTD | PMID:22150557 |
| capsaicin | multiple interactions | EXP | | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; more ... | CTD | PMID:22150557 |
| celecoxib | affects localization | ISO | RGD:733705 | 6480464 | celecoxib affects the localization of CTNNB1 protein; more ... | CTD | PMID:19682443 |
| chlordecone | decreases expression | ISO | RGD:733705 | 6480464 | Chlordecone results in decreased expression of CTNNB1 protein | CTD | PMID:11695219 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of CTNNB1 mRNA | CTD | PMID:20691718 |
| chromium(6+) | multiple interactions | ISO | RGD:733705 | 6480464 | CAT protein inhibits the reaction [chromium hexavalent ion results in increased expression of and results in increased activity of CTNNB1 protein]; more ... | CTD | PMID:22552367 |
| chromium(6+) | decreases expression | ISO | RGD:733705 | 6480464 | chromium hexavalent ion results in decreased expression of CTNNB1 protein | CTD | PMID:23518002 |
| chromium(6+) | increases expression | ISO | RGD:1550466 | 6480464 | chromium hexavalent ion results in increased expression of CTNNB1 protein | CTD | PMID:22552367 |
| cisplatin | decreases response to substance | ISO | RGD:733705 | 6480464 | CTNNB1 results in decreased susceptibility to Cisplatin | CTD | PMID:22000491 |
| cisplatin | increases expression | ISO | RGD:733705 | 6480464 | Cisplatin results in increased expression of CTNNB1 protein | CTD | PMID:20074550 |
| cisplatin | decreases localization | ISO | RGD:1550466 | 6480464 | Cisplatin results in decreased localization of CTNNB1 protein | CTD | PMID:21745194 |
| cisplatin | multiple interactions | ISO | RGD:1550466 | 6480464 | 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate inhibits the reaction [Cisplatin results in decreased localization of CTNNB1 protein]; more ... | CTD | PMID:21745194 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of CTNNB1 mRNA | CTD | PMID:17602206 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of CTNNB1 protein | CTD | PMID:16144542 |
| clozapine | multiple interactions | EXP | | 6480464 | DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein] | CTD | PMID:16144542 |
| cobalt dichloride | decreases expression | ISO | RGD:733705 | 6480464 | cobaltous chloride results in decreased expression of CTNNB1 mRNA | CTD | PMID:19320972 |
| cobalt dichloride | increases expression | ISO | RGD:733705 | 6480464 | cobaltous chloride results in increased expression of CTNNB1 mRNA | CTD | PMID:17553155 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of CTNNB1 mRNA | CTD | PMID:20187946 |
| corticosterone | multiple interactions | ISO | RGD:1550466 | 6480464 | [Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; more ... | CTD | PMID:21655274 |
| crocidolite asbestos | affects expression | ISO | RGD:733705 | 6480464 | Asbestos, Crocidolite affects the expression of CTNNB1 mRNA | CTD | PMID:17331233 |
| curcumin | decreases expression | ISO | RGD:733705 | 6480464 | Curcumin analog results in decreased expression of CTNNB1 mRNA; more ... | CTD | PMID:17041101 |
| curcumin | decreases expression | ISO | RGD:1550466 | 6480464 | Curcumin results in decreased expression of CTNNB1 protein | CTD | PMID:10783313 |
| curcumin | decreases expression | ISO | RGD:733705 | 6480464 | Curcumin results in decreased expression of CTNNB1 protein | CTD | PMID:19573523 |
| curcumin | multiple interactions | ISO | RGD:733705 | 6480464 | Curcumin inhibits the reaction [CTNNB1 protein binds to TCF7L2 protein]; more ... | CTD | PMID:19294764 |
| curcumin | increases degradation | ISO | RGD:733705 | 6480464 | Curcumin analog results in increased degradation of CTNNB1 protein; more ... | CTD | PMID:17041101 |
| cyclosporin A | decreases expression | ISO | RGD:733705 | 6480464 | Cyclosporine results in decreased expression of CTNNB1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1550466 | 6480464 | Cyclosporine results in decreased expression of CTNNB1 protein | CTD | PMID:22416070 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of CTNNB1 protein | CTD | PMID:18004065 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of CTNNB1 mRNA | CTD | PMID:21818840 |
| D-glucose | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] | CTD | PMID:18004065 |
| DDT | multiple interactions | ISO | RGD:733705 | 6480464 | DDT inhibits the reaction [CDH1 protein binds to CTNNB1 protein] | CTD | PMID:22902829 |
| DDT | increases expression | ISO | RGD:733705 | 6480464 | DDT results in increased expression of CTNNB1 protein | CTD | PMID:22902829 |
| delta-tocotrienol | decreases expression | ISO | RGD:733705 | 6480464 | tocotrienol, delta results in decreased expression of CTNNB1 protein | CTD | PMID:21453743 |
| desferrioxamine B | multiple interactions | ISO | RGD:733705 | 6480464 | Deferoxamine inhibits the reaction [ferumoxides results in increased activity of CTNNB1 protein] | CTD | PMID:20338187 |
| dexamethasone | decreases expression | ISO | RGD:1550466 | 6480464 | Dexamethasone results in decreased expression of CTNNB1 protein | CTD | PMID:20578217 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CTNNB1 protein | CTD | PMID:18467435 |
| dextran sulfate | increases expression | ISO | RGD:1550466 | 6480464 | Dextran Sulfate results in increased expression of CTNNB1 protein | CTD | PMID:16049979 |
| dextran sulfate | multiple interactions | ISO | RGD:1550466 | 6480464 | [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased mutagenesis of CTNNB1 gene; more ... | CTD | PMID:15459021 |
| diallyl disulfide | increases expression | ISO | RGD:733705 | 6480464 | diallyl disulfide results in increased expression of CTNNB1 mRNA; more ... | CTD | PMID:20600798 |
| diarsenic trioxide | decreases expression | ISO | RGD:733705 | 6480464 | arsenic trioxide results in decreased expression of CTNNB1 protein | CTD | PMID:18485479 PMID:17512576 |
| diarsenic trioxide | increases expression | ISO | RGD:733705 | 6480464 | arsenic trioxide results in increased expression of CTNNB1 mRNA | CTD | PMID:20458559 |
| diarsenic trioxide | increases cleavage | ISO | RGD:733705 | 6480464 | arsenic trioxide results in increased cleavage of CTNNB1 protein | CTD | PMID:12181429 |
| diarsenic trioxide | decreases expression | ISO | RGD:733705 | 6480464 | arsenic trioxide results in decreased expression of CTNNB1 protein | CTD | PMID:17512576 PMID:18485479 |
| diarsenic trioxide | decreases expression | ISO | RGD:733705 | 6480464 | arsenic trioxide results in decreased expression of CTNNB1 mRNA | CTD | PMID:18485479 |
| diarsenic trioxide | multiple interactions | ISO | RGD:733705 | 6480464 | arsenic trioxide inhibits the reaction [CTNNB1 protein results in decreased susceptibility to bortezomib] | CTD | PMID:18485479 |
| diazoxide | multiple interactions | ISO | RGD:733705 | 6480464 | Diazoxide inhibits the reaction [CTNNB1 protein results in increased activity of CCND1 promoter] | CTD | PMID:19052819 |
| diazoxide | decreases expression | ISO | RGD:733705 | 6480464 | Diazoxide results in decreased expression of CTNNB1 protein | CTD | PMID:19052819 |
| dibutyl phthalate | affects localization | ISO | RGD:733705 | 6480464 | Dibutyl Phthalate affects the localization of CTNNB1 protein | CTD | PMID:22552774 |
| dibutyl phthalate | multiple interactions | ISO | RGD:733705 | 6480464 | HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein]; more ... | CTD | PMID:22552774 |
| dichloromethane | increases mutagenesis | ISO | RGD:1550466 | 6480464 | Methylene Chloride results in increased mutagenesis of CTNNB1 gene | CTD | PMID:10467420 |
| diethylstilbestrol | increases expression | ISO | RGD:1550466 | 6480464 | Diethylstilbestrol results in increased expression of CTNNB1 mRNA | CTD | PMID:14648872 |
| dimethyl sulfoxide | increases expression | ISO | RGD:733705 | 6480464 | Dimethyl Sulfoxide results in increased expression of CTNNB1 protein | CTD | PMID:20091315 |
| dioxygen | multiple interactions | ISO | RGD:1550466 | 6480464 | [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein; more ... | CTD | PMID:16272459 |
| dioxygen | multiple interactions | ISO | RGD:733705 | 6480464 | [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in decreased expression of CTNNB1]; more ... | CTD | PMID:22245592 |
| dioxygen | decreases acetylation | ISO | RGD:733705 | 6480464 | Oxygen deficiency results in decreased acetylation of CTNNB1 protein | CTD | PMID:22245592 |
| dioxygen | decreases expression | ISO | RGD:733705 | 6480464 | Oxygen deficiency results in decreased expression of CTNNB1 mRNA | CTD | PMID:17175027 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of CTNNB1 mRNA | CTD | PMID:21551480 |
| doxorubicin | decreases response to substance | ISO | RGD:1550466 | 6480464 | CTNNB1 gene mutant form results in decreased susceptibility to Doxorubicin | CTD | PMID:20237062 |
| doxorubicin | multiple interactions | ISO | RGD:733705 | 6480464 | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin; more ... | CTD | PMID:19047049 |
| doxorubicin | increases expression | ISO | RGD:1550466 | 6480464 | Doxorubicin results in increased expression of CTNNB1 protein | CTD | PMID:20237062 |
| eckol | decreases expression | ISO | RGD:733705 | 6480464 | eckol results in decreased expression of CTNNB1 protein | CTD | PMID:21514314 |
| endosulfan | multiple interactions | ISO | RGD:733705 | 6480464 | Endosulfan results in increased expression of and affects the localization of CTNNB1 protein | CTD | PMID:22677888 |
| endosulfan | multiple interactions | ISO | RGD:733705 | 6480464 | Endosulfan inhibits the reaction [CDH1 protein binds to CTNNB1 protein] | CTD | PMID:22902829 |
| etoposide | multiple interactions | ISO | RGD:733705 | 6480464 | [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein]; more ... | CTD | PMID:19047049 |
| fluoxetine | multiple interactions | EXP | | 6480464 | [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA | CTD | PMID:21627639 |
| fluoxetine | multiple interactions | EXP | | 6480464 | Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of CTNNB1 protein] | CTD | PMID:21619414 |
| flutamide | affects localization | ISO | RGD:733705 | 6480464 | Flutamide analog affects the localization of CTNNB1 protein | CTD | PMID:21111724 |
| folic acid | affects expression | ISO | RGD:733705 | 6480464 | Folic Acid affects the expression of CTNNB1 mRNA | CTD | PMID:16361273 |
| folic acid | multiple interactions | ISO | RGD:1550466 | 6480464 | [Folic Acid co-treated with sodium arsenite] results in increased methylation of CTNNB1 mRNA | CTD | PMID:22959928 |
| fumonisin B1 | increases expression | ISO | RGD:1550466 | 6480464 | fumonisin B1 results in increased expression of CTNNB1 mRNA | CTD | PMID:16221962 |
| geldanamycin | multiple interactions | ISO | RGD:733705 | 6480464 | geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]; more ... | CTD | PMID:17024233 |
| genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein | CTD | PMID:16443925 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of CTNNB1 protein | CTD | PMID:18004065 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of CTNNB1 mRNA | CTD | PMID:21818840 |
| glucose | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] | CTD | PMID:18004065 |
| haloperidol | multiple interactions | EXP | | 6480464 | DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein] | CTD | PMID:16144542 |
| haloperidol | decreases expression | ISO | RGD:1550466 | 6480464 | Haloperidol results in decreased expression of CTNNB1 mRNA | CTD | PMID:18797397 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of CTNNB1 protein | CTD | PMID:16144542 |
| heptachlor | multiple interactions | ISO | RGD:733705 | 6480464 | Heptachlor inhibits the reaction [CDH1 protein binds to CTNNB1 protein] | CTD | PMID:22902829 |
| heptachlor | increases expression | ISO | RGD:733705 | 6480464 | Heptachlor results in increased expression of CTNNB1 protein | CTD | PMID:22902829 |
| hyaluronic acid | multiple interactions | ISO | RGD:733705 | 6480464 | [[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin; more ... | CTD | PMID:19047049 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of CTNNB1 protein | CTD | PMID:16204253 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein]; more ... | CTD | PMID:16204253 |
| hydrogen peroxide | decreases expression | ISO | RGD:733705 | 6480464 | Hydrogen Peroxide results in decreased expression of CTNNB1 mRNA | CTD | PMID:12419474 |
| indomethacin | affects localization | ISO | RGD:733705 | 6480464 | Indomethacin affects the localization of CTNNB1 protein | CTD | PMID:15963497 |
| indomethacin | decreases expression | ISO | RGD:733705 | 6480464 | Indomethacin results in decreased expression of CTNNB1 protein | CTD | PMID:15188006 PMID:11756231 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CTNNB1 protein | CTD | PMID:16818512 |
| indomethacin | multiple interactions | EXP | | 6480464 | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein]; more ... | CTD | PMID:16818512 |
| indomethacin | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride inhibits the reaction [Indomethacin results in increased phosphorylation of CTNNB1 protein] | CTD | PMID:12813129 |
| indomethacin | increases phosphorylation | ISO | RGD:733705 | 6480464 | Indomethacin results in increased phosphorylation of CTNNB1 protein | CTD | PMID:12813129 |
| indomethacin | decreases expression | ISO | RGD:733705 | 6480464 | Indomethacin results in decreased expression of CTNNB1 protein | CTD | PMID:11756231 PMID:15188006 |
| indomethacin | decreases expression | ISO | RGD:733705 | 6480464 | Indomethacin results in decreased expression of CTNNB1 mRNA | CTD | PMID:11756231 |
| indomethacin | multiple interactions | ISO | RGD:733705 | 6480464 | Indomethacin inhibits the reaction [[CTNNB1 protein binds to TCF7L2 protein] which binds to CCND1 promoter]; more ... | CTD | PMID:11756231 |
| ketanserin | multiple interactions | EXP | | 6480464 | [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA | CTD | PMID:21627639 |
| lactacystin | multiple interactions | ISO | RGD:733705 | 6480464 | lactacystin inhibits the reaction [Indomethacin results in decreased expression of CTNNB1 protein] | CTD | PMID:11756231 |
| lead(0) | decreases expression | ISO | RGD:1550466 | 6480464 | Lead results in decreased expression of CTNNB1 mRNA | CTD | PMID:23086611 |
| lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of CTNNB1 mRNA; more ... | CTD | PMID:23086611 |
| lithium atom | increases expression | ISO | RGD:1550466 | 6480464 | Lithium results in increased expression of CTNNB1 protein | CTD | PMID:19621015 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of CTNNB1 protein | CTD | PMID:12942141 PMID:18296634 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of CTNNB1 protein | CTD | PMID:18296634 PMID:12942141 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium results in increased expression of and affects the localization of CTNNB1 protein | CTD | PMID:16288908 |
| lithium atom | decreases expression | EXP | | 6480464 | Lithium results in decreased expression of CTNNB1 mRNA | CTD | PMID:12942141 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA] | CTD | PMID:19149911 |
| lithium atom | affects localization | EXP | | 6480464 | Lithium affects the localization of CTNNB1 protein | CTD | PMID:18296634 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | CTNNB1 protein affects the reaction [[Lithium Chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein] | CTD | PMID:19274078 |
| lithium chloride | increases stability | ISO | RGD:1550466 | 6480464 | Lithium Chloride results in increased stability of CTNNB1 protein | CTD | PMID:23326414 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of and results in decreased phosphorylation of CTNNB1 protein | CTD | PMID:19228266 |
| lithium chloride | increases expression | ISO | RGD:1550466 | 6480464 | Lithium Chloride results in increased expression of CTNNB1 protein | CTD | PMID:22935447 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein]; more ... | CTD | PMID:22935447 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased localization of and results in increased activity of CTNNB1 protein | CTD | PMID:20696143 |
| lithium chloride | increases activity | EXP | | 6480464 | Lithium Chloride results in increased activity of CTNNB1 protein | CTD | PMID:20694829 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | [Lithium Chloride results in decreased activity of and results in increased phosphorylation of GSK3B protein] which results in increased expression of and results in increased phosphorylation of CTNNB1 protein; more ... | CTD | PMID:22493441 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein] | CTD | PMID:22134133 |
| lithium chloride | affects localization | ISO | RGD:733705 | 6480464 | Lithium Chloride affects the localization of CTNNB1 protein; more ... | CTD | PMID:22493441 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of and results in increased localization of CTNNB1 protein | CTD | PMID:19679347 PMID:20074550 |
| lithium chloride | increases expression | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of CTNNB1 protein | CTD | PMID:16735606 more ... |
| lithium chloride | increases expression | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of CTNNB1 protein | CTD | PMID:16735606 more ... |
| lithium chloride | increases expression | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of CTNNB1 protein | CTD | PMID:16053526 more ... |
| lithium chloride | increases activity | ISO | RGD:1550466 | 6480464 | Lithium Chloride results in increased activity of CTNNB1 protein | CTD | PMID:20118494 PMID:19582394 |
| lithium chloride | increases expression | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of CTNNB1 protein | CTD | PMID:16053526 more ... |
| lithium chloride | multiple interactions | EXP | | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein; more ... | CTD | PMID:18972237 |
| lithium chloride | increases localization | ISO | RGD:1550466 | 6480464 | Lithium Chloride results in increased localization of CTNNB1 protein | CTD | PMID:19442631 |
| lithium chloride | multiple interactions | ISO | RGD:1550466 | 6480464 | Lithium Chloride results in increased expression of and affects the localization of CTNNB1 protein | CTD | PMID:15364539 |
| lithium chloride | multiple interactions | ISO | RGD:1550466 | 6480464 | [Lithium Chloride results in increased activity of CTNNB1 protein] which results in increased expression of GSTM3 mRNA | CTD | PMID:20118494 |
| lithium chloride | increases activity | ISO | RGD:1550466 | 6480464 | Lithium Chloride results in increased activity of CTNNB1 protein | CTD | PMID:19582394 PMID:20118494 |
| lithium chloride | multiple interactions | ISO | RGD:1550466 | 6480464 | Lithium Chloride promotes the reaction [CTNNB1 protein binds to GCG promoter]; more ... | CTD | PMID:19582394 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | SFRP2 protein affects the reaction [Lithium Chloride results in increased expression of CTNNB1 mRNA] | CTD | PMID:20069066 |
| lithium chloride | increases expression | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of CTNNB1 mRNA | CTD | PMID:20069066 |
| lithium chloride | increases expression | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of CTNNB1 protein | CTD | PMID:20069066 more ... |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride results in increased expression of and results in increased localization of CTNNB1 protein | CTD | PMID:20074550 PMID:19679347 |
| lithium chloride | decreases phosphorylation | ISO | RGD:733705 | 6480464 | Lithium Chloride results in decreased phosphorylation of CTNNB1 protein | CTD | PMID:16076840 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Lithium Chloride inhibits the reaction [Indomethacin results in increased phosphorylation of CTNNB1 protein]; more ... | CTD | PMID:12813129 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | Hexachlorophene inhibits the reaction [Lithium Chloride results in increased expression of CTNNB1 protein] | CTD | PMID:16735606 |
| lithium chloride | multiple interactions | ISO | RGD:733705 | 6480464 | CTNNB1 protein promotes the reaction [Lithium Chloride results in increased expression of POU5F1 protein]; more ... | CTD | PMID:20074550 |
| lovastatin | decreases degradation | EXP | | 6480464 | Lovastatin results in decreased degradation of CTNNB1 protein | CTD | PMID:19741129 |
| lovastatin | multiple interactions | ISO | RGD:733705 | 6480464 | Lovastatin affects the localization of and results in increased expression of CTNNB1 protein | CTD | PMID:17234346 |
| lupeol | decreases expression | ISO | RGD:1550466 | 6480464 | lupeol results in decreased expression of CTNNB1 protein | CTD | PMID:20979057 |
| lupeol | multiple interactions | ISO | RGD:733705 | 6480464 | lupeol results in decreased localization of and results in decreased activity of CTNNB1 protein | CTD | PMID:20732907 |
| LY294002 | multiple interactions | ISO | RGD:733705 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA2 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein]; more ... | CTD | PMID:19814765 |
| LY294002 | multiple interactions | ISO | RGD:733705 | 6480464 | [Tamoxifen co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects the localization of CTNNB1 protein | CTD | PMID:22046442 |
| LY294002 | multiple interactions | ISO | RGD:1550466 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased stability of CTNNB1 protein] | CTD | PMID:20542495 |
| LY294002 | multiple interactions | ISO | RGD:733705 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite affects the localization of CTNNB1 protein] | CTD | PMID:22859221 |
| manganese atom | decreases expression | ISO | RGD:733705 | 6480464 | Manganese results in decreased expression of CTNNB1 mRNA | CTD | PMID:17175027 |
| manganese(0) | decreases expression | ISO | RGD:733705 | 6480464 | Manganese results in decreased expression of CTNNB1 mRNA | CTD | PMID:17175027 |
| manganese(II) chloride | decreases expression | ISO | RGD:733705 | 6480464 | manganese chloride results in decreased expression of CTNNB1 mRNA | CTD | PMID:17175027 |
| methamphetamine | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA] | CTD | PMID:19149911 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of CTNNB1 mRNA | CTD | PMID:19149911 |
| methotrexate | multiple interactions | ISO | RGD:733705 | 6480464 | Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein] | CTD | PMID:19727391 |
| methoxychlor | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein | CTD | PMID:16443925 |
| microcystin-LR | increases ubiquitination | ISO | RGD:733705 | 6480464 | cyanoginosin LR results in increased ubiquitination of CTNNB1 protein | CTD | PMID:20421190 |
| mifepristone | increases expression | ISO | RGD:733705 | 6480464 | Mifepristone results in increased expression of CTNNB1 mRNA | CTD | PMID:17584828 |
| monocrotaline | multiple interactions | EXP | | 6480464 | Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of CTNNB1 protein] | CTD | PMID:21619414 |
| monocrotaline | decreases expression | EXP | | 6480464 | Monocrotaline results in decreased expression of CTNNB1 protein | CTD | PMID:21619414 |
| myricetin | decreases expression | ISO | RGD:733705 | 6480464 | myricetin results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| myricetin | multiple interactions | ISO | RGD:733705 | 6480464 | [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| N(6),N(6)-dimethyladenine | multiple interactions | EXP | | 6480464 | N(6),N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of CTNNB1 protein] | CTD | PMID:15618353 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1550466 | 6480464 | Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein] | CTD | PMID:19436114 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:733705 | 6480464 | Acetylcysteine inhibits the reaction [NCX 4040 results in increased cleavage of CTNNB1 protein] | CTD | PMID:16282376 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:1550466 | 6480464 | Methylnitrosourea results in increased expression of CTNNB1 protein | CTD | PMID:12096346 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1550466 | 6480464 | CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:20583210 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of CTNNB1 mRNA | CTD | PMID:21554863 |
| N-nitrosodiethylamine | affects localization | EXP | | 6480464 | Diethylnitrosamine affects the localization of CTNNB1 protein modified form | CTD | PMID:21554863 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine affects the localization of CTNNB1 protein modified form]; more ... | CTD | PMID:21554863 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1550466 | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in increased mutagenesis of CTNNB1 gene | CTD | PMID:21047994 |
| N-nitrosodiethylamine | increases mutagenesis | EXP | | 6480464 | Diethylnitrosamine results in increased mutagenesis of CTNNB1 | CTD | PMID:10463579 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1550466 | 6480464 | Diethylnitrosamine results in increased expression of CTNNB1 protein | CTD | PMID:20583210 |
| N-nitrosodiethylamine | decreases response to substance | ISO | RGD:1550466 | 6480464 | CTNNB1 protein results in decreased susceptibility to Diethylnitrosamine | CTD | PMID:20583210 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:733705 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin inhibits the reaction [CTNNB1 protein binds to TCF4 protein]]; more ... | CTD | PMID:17030184 |
| naproxen | multiple interactions | EXP | | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; more ... | CTD | PMID:22150557 |
| nimesulide | affects localization | ISO | RGD:733705 | 6480464 | nimesulide affects the localization of CTNNB1 protein | CTD | PMID:16331303 |
| nimesulide | decreases expression | ISO | RGD:1550466 | 6480464 | nimesulide results in decreased expression of CTNNB1 | CTD | PMID:15892897 |
| nitroglycerin | multiple interactions | ISO | RGD:733705 | 6480464 | 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein]; more ... | CTD | PMID:17030184 |
| nitroglycerin | decreases localization | ISO | RGD:733705 | 6480464 | Nitroglycerin results in decreased localization of CTNNB1 protein | CTD | PMID:17030184 |
| O-methyleugenol | increases mutagenesis | ISO | RGD:1550466 | 6480464 | methyleugenol results in increased mutagenesis of CTNNB1 gene | CTD | PMID:10467420 |
| okadaic acid | increases phosphorylation | ISO | RGD:733705 | 6480464 | Okadaic Acid results in increased phosphorylation of CTNNB1 protein | CTD | PMID:16878161 |
| olanzapine | decreases expression | ISO | RGD:1550466 | 6480464 | olanzapine results in decreased expression of CTNNB1 mRNA | CTD | PMID:18797397 |
| oxazepam | increases mutagenesis | ISO | RGD:1550466 | 6480464 | Oxazepam results in increased mutagenesis of CTNNB1 gene | CTD | PMID:10467420 |
| paclitaxel | decreases response to substance | ISO | RGD:733705 | 6480464 | CTNNB1 results in decreased susceptibility to Paclitaxel | CTD | PMID:22000491 |
| paracetamol | affects expression | ISO | RGD:1550466 | 6480464 | Acetaminophen affects the expression of CTNNB1 mRNA | CTD | PMID:17562736 PMID:19679878 |
| paracetamol | increases expression | ISO | RGD:733705 | 6480464 | Acetaminophen results in increased expression of CTNNB1 mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:1550466 | 6480464 | Acetaminophen affects the expression of CTNNB1 mRNA | CTD | PMID:19679878 PMID:17562736 |
| paracetamol | increases response to substance | ISO | RGD:1550466 | 6480464 | CTNNB1 mutant form results in increased susceptibility to Acetaminophen | CTD | PMID:19679878 |
| paracetamol | multiple interactions | ISO | RGD:1550466 | 6480464 | Acetaminophen results in increased expression of and results in increased activity of CTNNB1 protein | CTD | PMID:19679878 |
| paracetamol | affects localization | ISO | RGD:1550466 | 6480464 | Acetaminophen affects the localization of CTNNB1 protein | CTD | PMID:19679878 |
| parathion | multiple interactions | ISO | RGD:733705 | 6480464 | Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form]; more ... | CTD | PMID:17390078 |
| parathion | increases expression | ISO | RGD:733705 | 6480464 | Parathion results in increased expression of CTNNB1 protein | CTD | PMID:17390078 |
| phenobarbital | affects response to substance | ISO | RGD:1550466 | 6480464 | CTNNB1 protein affects the susceptibility to Phenobarbital | CTD | PMID:21705713 |
| phenobarbital | multiple interactions | ISO | RGD:1550466 | 6480464 | CTNNB1 protein affects the reaction [Phenobarbital results in increased expression of MEG3 mRNA]; more ... | CTD | PMID:23091169 |
| phenobarbital | increases mutagenesis | ISO | RGD:1550466 | 6480464 | Phenobarbital results in increased mutagenesis of CTNNB1 protein | CTD | PMID:11753661 |
| phenobarbital | multiple interactions | ISO | RGD:1550466 | 6480464 | [Phenobarbital results in increased mutagenesis of CTNNB1 gene] which results in increased expression of GLUL mRNA; more ... | CTD | PMID:12384525 |
| phenobarbital | increases mutagenesis | ISO | RGD:1550466 | 6480464 | Phenobarbital results in increased mutagenesis of CTNNB1 gene | CTD | PMID:12384525 |
| phenobarbital | multiple interactions | ISO | RGD:1550466 | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in increased mutagenesis of CTNNB1 gene | CTD | PMID:21047994 |
| phenobarbital | multiple interactions | ISO | RGD:1550466 | 6480464 | [Phenobarbital co-treated with CTNNB1 protein mutant form] results in increased expression of GSTM2 mRNA; more ... | CTD | PMID:20118494 |
| phenylephrine | multiple interactions | EXP | | 6480464 | Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter] | CTD | PMID:19799869 |
| pioglitazone | multiple interactions | ISO | RGD:733705 | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA | CTD | PMID:20847119 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [APP protein results in decreased expression of CTNNB1 protein]; more ... | CTD | PMID:16204253 |
| pirinixic acid | decreases expression | ISO | RGD:1550466 | 6480464 | pirinixic acid results in decreased expression of CTNNB1 mRNA | CTD | PMID:18445702 |
| pravastatin | affects localization | EXP | | 6480464 | Pravastatin affects the localization of CTNNB1 protein | CTD | PMID:17188708 |
| pravastatin | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein | CTD | PMID:17188708 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of CTNNB1 protein | CTD | PMID:17170212 |
| prostaglandin E2 | increases localization | ISO | RGD:733705 | 6480464 | Dinoprostone results in increased localization of CTNNB1 protein | CTD | PMID:18395713 |
| puromycin | affects localization | ISO | RGD:1550466 | 6480464 | Puromycin affects the localization of CTNNB1 protein | CTD | PMID:15673299 |
| pyrithione | multiple interactions | EXP | | 6480464 | [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein | CTD | PMID:17098228 |
| quercetin | affects expression | ISO | RGD:733705 | 6480464 | Quercetin affects the expression of CTNNB1 protein | CTD | PMID:15670774 |
| quercetin | multiple interactions | ISO | RGD:733705 | 6480464 | [Quercetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| quercetin | decreases expression | ISO | RGD:733705 | 6480464 | Quercetin results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| quercetin | decreases activity | ISO | RGD:733705 | 6480464 | Quercetin results in decreased activity of CTNNB1 protein | CTD | PMID:15670774 PMID:19440933 |
| quercetin | decreases activity | ISO | RGD:733705 | 6480464 | Quercetin results in decreased activity of CTNNB1 protein | CTD | PMID:19440933 PMID:15670774 |
| quercetin | multiple interactions | ISO | RGD:733705 | 6480464 | Quercetin inhibits the reaction [DEFA1 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein]; more ... | CTD | PMID:19814765 |
| quercetin | multiple interactions | ISO | RGD:733705 | 6480464 | Quercetin inhibits the reaction [CTNNB1 protein binds to TCF4 protein] | CTD | PMID:15670774 |
| resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 protein | CTD | PMID:11895924 more ... |
| resveratrol | affects localization | ISO | RGD:1550466 | 6480464 | resveratrol affects the localization of CTNNB1 protein | CTD | PMID:19665018 |
| resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:19047049 |
| resveratrol | increases stability | ISO | RGD:1550466 | 6480464 | resveratrol results in increased stability of CTNNB1 protein | CTD | PMID:20542495 |
| resveratrol | multiple interactions | ISO | RGD:1550466 | 6480464 | resveratrol inhibits the reaction [WNT3A protein promotes the reaction [TCF4 protein binds to CTNNB1 protein]]; more ... | CTD | PMID:22935447 |
| resveratrol | multiple interactions | ISO | RGD:1550466 | 6480464 | CTNNB1 protein promotes the reaction [resveratrol results in increased expression of SOD2 protein]; more ... | CTD | PMID:20542495 |
| resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 protein | CTD | PMID:18347188 PMID:22245592 |
| resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 mRNA | CTD | PMID:18347188 |
| resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | resveratrol inhibits the reaction [Lithium Chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein]]; more ... | CTD | PMID:22935447 |
| resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | CTNNB1 protein promotes the reaction [resveratrol results in increased expression of VEGFA protein]; more ... | CTD | PMID:20696143 |
| resveratrol | increases activity | ISO | RGD:1550466 | 6480464 | resveratrol results in increased activity of CTNNB1 protein | CTD | PMID:19665018 |
| resveratrol | increases stability | ISO | RGD:1550466 | 6480464 | resveratrol results in increased stability of CTNNB1 protein | CTD | PMID:19665018 PMID:20542495 |
| resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein | CTD | PMID:17188708 |
| resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of CTNNB1 protein | CTD | PMID:17188708 |
| resveratrol | affects localization | ISO | RGD:733705 | 6480464 | resveratrol affects the localization of CTNNB1 protein | CTD | PMID:22314268 |
| riboflavin | increases expression | ISO | RGD:1550466 | 6480464 | Riboflavin analog results in increased expression of CTNNB1 protein | CTD | PMID:20688149 |
| risperidone | multiple interactions | EXP | | 6480464 | DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein] | CTD | PMID:16144542 |
| risperidone | increases expression | EXP | | 6480464 | Risperidone results in increased expression of CTNNB1 protein | CTD | PMID:16144542 |
| rosiglitazone | multiple interactions | ISO | RGD:733705 | 6480464 | [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; more ... | CTD | PMID:20847119 |
| rosiglitazone | increases expression | ISO | RGD:1550466 | 6480464 | rosiglitazone results in increased expression of CTNNB1 protein | CTD | PMID:19621015 |
| simvastatin | multiple interactions | ISO | RGD:1550466 | 6480464 | CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of BGLAP protein]; more ... | CTD | PMID:22058016 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of CTNNB1 protein | CTD | PMID:18004065 |
| simvastatin | increases expression | ISO | RGD:1550466 | 6480464 | Simvastatin results in increased expression of CTNNB1 protein | CTD | PMID:22058016 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] | CTD | PMID:18004065 |
| staurosporine | increases phosphorylation | EXP | | 6480464 | Staurosporine results in increased phosphorylation of CTNNB1 protein | CTD | PMID:19741129 |
| sulfasalazine | multiple interactions | ISO | RGD:1550466 | 6480464 | [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA | CTD | PMID:19015640 |
| sulindac | multiple interactions | ISO | RGD:733705 | 6480464 | CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein]; more ... | CTD | PMID:18291362 |
| sulindac | decreases expression | ISO | RGD:1550466 | 6480464 | Sulindac results in decreased expression of CTNNB1 protein | CTD | PMID:10223192 |
| sulindac | multiple interactions | ISO | RGD:1550466 | 6480464 | [Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein | CTD | PMID:12351151 |
| sulindac | decreases expression | ISO | RGD:733705 | 6480464 | Sulindac results in decreased expression of CTNNB1 protein | CTD | PMID:18291362 |
| sulindac | multiple interactions | ISO | RGD:733705 | 6480464 | Sulindac results in decreased activity of [LEF1 protein binds to CTNNB1 protein] | CTD | PMID:11751639 |
| sumatriptan | multiple interactions | EXP | | 6480464 | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein]; more ... | CTD | PMID:22150557 |
| tamoxifen | multiple interactions | ISO | RGD:733705 | 6480464 | [Tamoxifen co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects the localization of CTNNB1 protein | CTD | PMID:22046442 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:733705 | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; more ... | CTD | PMID:20847119 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:733705 | 6480464 | tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA | CTD | PMID:20847119 |
| testosterone | increases expression | ISO | RGD:733705 | 6480464 | Testosterone results in increased expression of CTNNB1 protein | CTD | PMID:21468052 |
| testosterone | increases expression | ISO | RGD:1550466 | 6480464 | Testosterone results in increased expression of CTNNB1 protein | CTD | PMID:21468052 |
| topotecan | multiple interactions | ISO | RGD:733705 | 6480464 | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein]; more ... | CTD | PMID:20457140 |
| topotecan | increases cleavage | ISO | RGD:733705 | 6480464 | Topotecan results in increased cleavage of CTNNB1 protein | CTD | PMID:20457140 |
| trans-resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 protein | CTD | PMID:11895924 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | resveratrol inhibits the reaction [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:19047049 |
| trans-resveratrol | affects localization | ISO | RGD:1550466 | 6480464 | resveratrol affects the localization of CTNNB1 protein | CTD | PMID:19665018 |
| trans-resveratrol | increases stability | ISO | RGD:1550466 | 6480464 | resveratrol results in increased stability of CTNNB1 protein | CTD | PMID:20542495 |
| trans-resveratrol | multiple interactions | ISO | RGD:1550466 | 6480464 | resveratrol inhibits the reaction [WNT3A protein promotes the reaction [TCF4 protein binds to CTNNB1 protein]]; more ... | CTD | PMID:22935447 |
| trans-resveratrol | multiple interactions | ISO | RGD:1550466 | 6480464 | CTNNB1 protein promotes the reaction [resveratrol results in increased expression of SOD2 protein]; more ... | CTD | PMID:20542495 |
| trans-resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 protein | CTD | PMID:18347188 PMID:22245592 |
| trans-resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 mRNA | CTD | PMID:18347188 |
| trans-resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | resveratrol inhibits the reaction [Lithium Chloride results in increased activity of [TCF4 protein co-treated with CTNNB1 protein]]; more ... | CTD | PMID:22935447 |
| trans-resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | CTNNB1 protein promotes the reaction [resveratrol results in increased expression of VEGFA protein]; more ... | CTD | PMID:20696143 |
| trans-resveratrol | increases activity | ISO | RGD:1550466 | 6480464 | resveratrol results in increased activity of CTNNB1 protein | CTD | PMID:19665018 |
| trans-resveratrol | increases stability | ISO | RGD:1550466 | 6480464 | resveratrol results in increased stability of CTNNB1 protein | CTD | PMID:19665018 PMID:20542495 |
| trans-resveratrol | multiple interactions | ISO | RGD:733705 | 6480464 | [resveratrol results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| trans-resveratrol | decreases expression | ISO | RGD:733705 | 6480464 | resveratrol results in decreased expression of CTNNB1 protein | CTD | PMID:22245592 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein | CTD | PMID:17188708 |
| trans-resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of CTNNB1 protein | CTD | PMID:17188708 |
| trans-resveratrol | affects localization | ISO | RGD:733705 | 6480464 | resveratrol affects the localization of CTNNB1 protein | CTD | PMID:22314268 |
| trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CTNNB1 mRNA | CTD | PMID:14565619 |
| trichostatin A | multiple interactions | ISO | RGD:733705 | 6480464 | [3-deazaneplanocin co-treated with trichostatin A] affects the expression of CTNNB1 protein | CTD | PMID:18538736 |
| trichostatin A | multiple interactions | ISO | RGD:733705 | 6480464 | trichostatin A inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein]; more ... | CTD | PMID:22552774 |
| trichostatin A | multiple interactions | ISO | RGD:1550466 | 6480464 | [estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein | CTD | PMID:15930180 |
| troglitazone | multiple interactions | ISO | RGD:733705 | 6480464 | [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; more ... | CTD | PMID:20847119 |
| troglitazone | decreases expression | ISO | RGD:1550466 | 6480464 | troglitazone results in decreased expression of CTNNB1 | CTD | PMID:15892897 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CTNNB1 protein | CTD | PMID:12942141 PMID:20734317 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CTNNB1 protein | CTD | PMID:20734317 PMID:12942141 |
| venlafaxine | increases expression | EXP | | 6480464 | venlafaxine results in increased expression of CTNNB1 protein | CTD | PMID:18511088 |
| vincristine | decreases response to substance | ISO | RGD:733705 | 6480464 | CTNNB1 results in decreased susceptibility to Vincristine | CTD | PMID:22000491 |
| vinyl carbamate | increases mutagenesis | ISO | RGD:1550466 | 6480464 | vinyl carbamate results in increased mutagenesis of CTNNB1 gene | CTD | PMID:10467420 |
| wortmannin | decreases expression | ISO | RGD:733705 | 6480464 | wortmannin results in decreased expression of CTNNB1 protein | CTD | PMID:11739494 |
| zinc atom | multiple interactions | ISO | RGD:733705 | 6480464 | Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] | CTD | PMID:16844947 |
| zinc atom | multiple interactions | EXP | | 6480464 | Zinc deficiency results in decreased activity of and results in decreased expression of CTNNB1 protein | CTD | PMID:21893222 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein | CTD | PMID:17098228 |
| zinc(0) | multiple interactions | ISO | RGD:733705 | 6480464 | Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] | CTD | PMID:16844947 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein | CTD | PMID:17098228 |
| zinc(0) | multiple interactions | EXP | | 6480464 | Zinc deficiency results in decreased activity of and results in decreased expression of CTNNB1 protein | CTD | PMID:21893222 |